Amdocs Limited (NASDAQ:DOX) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Amdocs Limited (NASDAQ:DOXGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the five ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $101.20.

Several research analysts have recently commented on the stock. Barclays lowered their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Finally, Oppenheimer boosted their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th.

Read Our Latest Analysis on Amdocs

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Private Trust Co. NA increased its position in Amdocs by 62.9% in the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after buying an additional 117 shares during the period. Brooklyn Investment Group acquired a new position in Amdocs in the third quarter worth $28,000. Global Retirement Partners LLC boosted its stake in Amdocs by 45.6% in the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock worth $48,000 after purchasing an additional 175 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new position in Amdocs in the third quarter worth $55,000. Finally, GAMMA Investing LLC lifted its stake in shares of Amdocs by 115.1% during the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock valued at $70,000 after acquiring an additional 428 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.

Amdocs Trading Down 0.9 %

Shares of DOX opened at $87.39 on Tuesday. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $9.87 billion, a P/E ratio of 20.61, a P/E/G ratio of 1.47 and a beta of 0.71. The firm has a 50-day moving average price of $85.97 and a 200 day moving average price of $86.35. Amdocs has a 12-month low of $74.41 and a 12-month high of $94.04.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Tuesday, December 31st. Amdocs’s dividend payout ratio (DPR) is presently 45.28%.

Amdocs Company Profile

(Get Free Report

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.